212 related articles for article (PubMed ID: 30628640)
21. Long non-coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR-363-3p.
Rong H; Chen B; Wei X; Peng J; Ma K; Duan S; He J
Thorac Cancer; 2020 Mar; 11(3):659-671. PubMed ID: 31968395
[TBL] [Abstract][Full Text] [Related]
22. An inhibitory effect on cell proliferation by blockage of the MAPK/estrogen receptor/MDM2 signal pathway in gynecologic cancer.
Suga S; Kato K; Ohgami T; Yamayoshi A; Adachi S; Asanoma K; Yamaguchi S; Arima T; Kinoshita K; Wake N
Gynecol Oncol; 2007 May; 105(2):341-50. PubMed ID: 17306348
[TBL] [Abstract][Full Text] [Related]
23. Targeting Thyroid Receptor Interacting Protein 6 by MicroRNA-589-5p Inhibits Cell Proliferation, Migration, and Invasion in Endometrial Carcinoma.
Wang Y; Dong L; Liu Y
Cancer Biother Radiopharm; 2019 Oct; 34(8):529-536. PubMed ID: 31424277
[No Abstract] [Full Text] [Related]
24. MDM2 and PSMA Play Inhibitory Roles in Metastatic Breast Cancer Cells Through Regulation of Matrix Metalloproteinases.
Bradbury R; Jiang WG; Cui YX
Anticancer Res; 2016 Mar; 36(3):1143-51. PubMed ID: 26977010
[TBL] [Abstract][Full Text] [Related]
25. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol reverses EGF-induced cell migration and invasion through down-regulation of MDM2 in breast cancer cell lines.
Zheng D; Chang X; Liu Y; Xu J; Gou W; Li Z; Zuo D; Zhang W; Wu Y
Cancer Biol Ther; 2019; 20(4):513-523. PubMed ID: 30514153
[TBL] [Abstract][Full Text] [Related]
26. P53/MDM2 overexpression in metastatic endometrial cancer: correlation with clinicopathological features and patient outcome.
Jeczen R; Skomra D; Cybulski M; Schneider-Stock R; Szewczuk W; Roessner A; Rechberger T; Semczuk A
Clin Exp Metastasis; 2007; 24(7):503-11. PubMed ID: 17671841
[TBL] [Abstract][Full Text] [Related]
27. Early Growth Response 1-Dependent Downregulation of Matrix Metalloproteinase 9 and Mouse Double Minute 2 Attenuates Head and Neck Squamous Cell Carcinoma Metastasis.
Kim J; Kang SM; Oh SY; Kang SH; Lee I; Hwang JC; Lee HJ; Choi SY; Hong SH
Cell Physiol Biochem; 2018; 50(5):1869-1881. PubMed ID: 30396177
[TBL] [Abstract][Full Text] [Related]
28. Synergistic suppression of prostatic cancer cells by coexpression of both murine double minute 2 small interfering RNA and wild-type p53 gene in vitro and in vivo.
Ji K; Wang B; Shao YT; Zhang L; Liu YN; Shao C; Li XJ; Li X; Hu JD; Zhao XJ; Xu DQ; Li Y; Cai L
J Pharmacol Exp Ther; 2011 Jul; 338(1):173-83. PubMed ID: 21444629
[TBL] [Abstract][Full Text] [Related]
29. Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial-mesenchymal transition.
Wen Y; Tan X; Wu X; Wu Q; Qin Y; Liang M; Ran G; Gu H; Xie R
Cancer Biomark; 2019; 26(1):21-30. PubMed ID: 31322544
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of p21-activated kinase 1 promotes endometrial cancer progression.
Lu W; Qu JJ; Li BL; Lu C; Yan Q; Wu XM; Chen XY; Wan XP
Oncol Rep; 2013 Apr; 29(4):1547-55. PubMed ID: 23338047
[TBL] [Abstract][Full Text] [Related]
31. Metformin inhibits proliferation and migration of endometrial cancer cells through regulating PI3K/AKT/MDM2 pathway.
Qiang P; Shao Y; Sun YP; Zhang J; Chen LJ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1778-1785. PubMed ID: 30840303
[TBL] [Abstract][Full Text] [Related]
32. [Effects of PPARγ gene expression on cell migration, invasion, and proliferation in endometrial cancer cells].
Xinxin H; Meng Z; Guiyu Z
Zhonghua Fu Chan Ke Za Zhi; 2014 May; 49(5):360-5. PubMed ID: 25030733
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of invasion and migration of prostate cancer cells by miRNA-509-5p via targeting MDM2.
Tian XM; Luo YZ; He P; Li J; Ma ZW; An Y
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252164
[TBL] [Abstract][Full Text] [Related]
34. Induction of p53 expression and apoptosis by a recombinant dual-target MDM2/MDMX inhibitory protein in wild-type p53 breast cancer cells.
Geng QQ; Dong DF; Chen NZ; Wu YY; Li EX; Wang J; Wang SM
Int J Oncol; 2013 Dec; 43(6):1935-42. PubMed ID: 24126697
[TBL] [Abstract][Full Text] [Related]
35. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
[TBL] [Abstract][Full Text] [Related]
36. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis.
Liu K; Xue B; Bai G; Zhang W
Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832
[TBL] [Abstract][Full Text] [Related]
37. TSPAN1 upregulates MMP2 to promote pancreatic cancer cell migration and invasion via PLCγ.
Zhang X; Shi G; Gao F; Liu P; Wang H; Tan X
Oncol Rep; 2019 Apr; 41(4):2117-2125. PubMed ID: 30720116
[TBL] [Abstract][Full Text] [Related]
38. eIF4E‑related miR‑320a and miR‑340‑5p inhibit endometrial carcinoma cell metastatic capability by preventing TGF‑β1‑induced epithelial‑mesenchymal transition.
Zhang HH; Li R; Li YJ; Yu XX; Sun QN; Li AY; Kong Y
Oncol Rep; 2020 Feb; 43(2):447-460. PubMed ID: 31894279
[TBL] [Abstract][Full Text] [Related]
39. PCAT1 is a poor prognostic factor in endometrial carcinoma and associated with cancer cell proliferation, migration and invasion.
Zhao X; Fan Y; Lu C; Li H; Zhou N; Sun G; Fan H
Bosn J Basic Med Sci; 2019 Aug; 19(3):274-281. PubMed ID: 31136293
[TBL] [Abstract][Full Text] [Related]
40. Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β-catenin pathway.
Sun X; Xing G; Zhang C; Lu K; Wang Y; He X
Cell Biochem Funct; 2020 Mar; 38(2):141-148. PubMed ID: 31967350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
